ArticleNPJ breast cancer2021

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk.

Mark Jesus M Magbanua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.